Definitive Contract 75D30120C09605
Award Date
9/30/20
Potential Completion Date
1/31/23
Potential Value
$4.4M
Federal Agency
CDC Pittsburgh
Awardee
The Broad Institute, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Cambridge, MA 02142, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
15
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Broad Institute, Inc., doing business as Broad Institute of MIT and Harvard, has been awarded a $807,756 firm fixed price purchase order by the Centers for Disease Control and Prevention (CDC) to deliver the TERRA platform under the CDC's Division of Disease Integration, National Center for Emerging and Zoonotic Infectious Diseases program. As a leading genomic research institution, Broad Institute will leverage its expertise to support CDC's efforts to advance infectious disease...
The Centers for Disease Control and Prevention awarded a $4,600,633 definitive cost-no-fee contract to The Broad Institute, Inc. to demonstrate pan-pathogen and pathogen-agnostic genomic surveillance of clinical respiratory disease. As a non-profit research organization, The Broad Institute will leverage its expertise in large-scale genomic and health data analysis, integration and management to support the CDC's infectious disease initiatives. No set-aside designation was used for this award...
The Centers for Disease Control and Prevention (CDC) awarded a sole source firm fixed price contract to The Broad Institute, Inc. to provide genomic sequencing of up to 5,000 SARS-CoV-2 samples per week from various jurisdictions. The contract has a potential value of $15,763,600.00 and includes two 13-week option periods to potentially sequence up to 10,000 samples per week. The Broad Institute, a non-profit research organization, will sequence the samples and submit the data to public...
This is a $2,226,582.00 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Broad Institute, Inc., doing business as Broad Institute of MIT and Harvard. The contract is for FY22 BAA TOPIC 7 and has a completion date of March 25, 2025. The Broad Institute is a non-profit biomedical and genomic research organization that frequently partners with government agencies like the NIH, CDC, DoD, and NSF to provide specialized scientific services...
This contract is for research and development services awarded by the Centers for Disease Control and Prevention (CDC) to The Broad Institute, Inc., doing business as Broad Institute of MIT and Harvard. The contract has a ceiling value of $1,029,999.88 and a completion date of September 29, 2026. It is a definitive contract with a cost-no-fee pricing type, and there is no set-aside designation. The Broad Institute is a non-profit biomedical and genomic research organization that frequently...
<p>The Centers for Disease Control and Prevention awarded a $3.7 million definitive cost-no-fee contract to The Broad Institute, Inc., doing business as Broad Institute of MIT and Harvard, to advance CRISPR-based diagnostics in response to ongoing pathogenic threats under Broad Agency Announcement topic 20.1. The place of performance will be Cambridge, Massachusetts and work is expected to be completed by January 31, 2024.</p>
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $2.5 million definitive contract to the Scripps Research Institute for genomic sequencing of SARS-CoV-2 to investigate local and cross-border emergence and spread. This contract was awarded under the Centers for Disease Control COVID-19 Broad Agency Announcement, which sought white papers related to developing strategies for protecting communities from COVID-19, including examining the virus's...
The Broad Institute, Inc., doing business as the Broad Institute of MIT and Harvard, has been awarded a definitive contract valued at $25.7 million by the National Institutes of Health's National Heart, Lung and Blood Institute to scale the Broad Institute's reverse transcription polymerase chain reaction (RT-PCR) process to support testing of over 100,000 samples per day. This contract is part of the Rapid Acceleration of Diagnostics (RADx) Advanced Technology Platforms program, which aims to...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $10.9 million firm fixed price purchase order to The Broad Institute, Inc. for serology and virus neutralization testing in support of coronavirus COVID-19 response efforts. Performance will take place at the prime contractor's Cambridge, Massachusetts location through September 2021. No subcontractors or set aside designations were indicated. This award utilizes the prime...
The Department of Veterans Affairs Veterans Health Administration awarded a $143,800 firm fixed price purchase order to Broad Clinical Laboratories, LLC, a subsidiary of the non-profit Broad Institute, Inc., to provide COVID-19 testing services for VISN1. The contract was awarded on April 10, 2020 and is scheduled to be completed by August 5, 2021. The Broad Institute, Inc. is a prominent biomedical and genomics research organization that has received over $500 million in federal contract awards...